Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Wf-516 is a 5-HT reuptake inhibitor (Kis: 5 nM and 40 nM for 5-HT1A receptor and 5-HT2A receptor in humans, respectively), and with potent antidepressant activity.
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
25 mg | ¥ 12,800 | 8-10周 | ||
50 mg | ¥ 16,800 | 8-10周 | ||
100 mg | ¥ 21,500 | 8-10周 |
产品描述 | Wf-516 is a 5-HT reuptake inhibitor (Kis: 5 nM and 40 nM for 5-HT1A receptor and 5-HT2A receptor in humans, respectively), and with potent antidepressant activity. |
靶点活性 | 5-HT1A receptor (human):ki:5 nM , 5-HT2A receptor (human):40 nM (ki) |
体外活性 | Wf-516 shows high affinity for 5-HT1A receptors in the hippocampus and raphe nucleus of rats(Ki of 8.1 nM and 7.9 nM, respectively)[2]. |
体内活性 | Wf-516 (0.5 mg/kg, i.v.) does not induce any change in the firing activity of 5-HT neurons, but significantly blocks the inhibitory effect of 8-OHDPAT (a 5-HT autoreceptor agonist) by 70%. A full dose-response relationship between the suppression of DRN firing activity and different doses of LSD shows a significant fourfold shift to the right in the Wf-516 pretreated rats (ED50?=?32.4?±?1.0 μg/kg) as compared to controls with ED50?of?7.5?±?1.2 μg/kg. After intravenous administration of successive doses of 1.25 mg/kg of Wf-516 (up to 10 mg/kg), the effect of microiontophoretically applied 5-HT is prolonged and reaches statistical significance at 7.5 mg/kg. At this dose, the RT50 value is increased by 53% and, by 75% at the highest dose of 10 mg/kg of Wf-516 used[1].Compared with baseline, oral administration of 30 mg/kg Wf-516 to these 5,7-DHT-treated rats induced a significant decrease in hippocampal BPND, but no further decrease in BPND was observed in the grooved nuclei. The oral ED50 values of Wf-516 in the hippocampus and grooved nuclei were 5.3 mg/kg and 4.2 mg/kg, respectively [2]. |
分子量 | 502.39 |
分子式 | C25H25Cl2N3O4 |
CAS No. | 310392-94-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Wf-516 310392-94-0 GPCR/G Protein Neuroscience 5-HT Receptor Wf516 Wf 516 Inhibitor inhibitor inhibit